Oncology Agents and Medication-Related Osteonecrosis of the Jaw
Document Type
Article
Publication Title
Oral Health Topics
Abstract
This OHT discusses medication-related osteonecrosis of the jaw (MRONJ) and oncology agents; types of antiresorptive and/or antiangiogenic medications used in oncology; and management approaches for dental patients receiving antiresorptive and/or antiangiogenic medications for cancer indications.
COinS